Evidence map›Paper›PMID 28031361›Full record

ArticleJournal of virology2017

Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.

Raphaëlle Riou, Céline Bressollette-Bodin, David Boutoille, Katia Gagne, Audrey Rodallec, Maeva Lefebvre, François Raffi, David Senitzer, Berthe-Marie Imbert-Marcille, Christelle Retière

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. IL-10-Secreting CD8Pathogens (Basel, Switzerland) · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Advances in the treatment of cytomegalovirus.British medical bulletin · 2019
    Article
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Raphaëlle RiouEtablissement Français du Sang, Nantes, France.
Céline Bressollette-BodinCentre de Recherche en Transplantation et Immunologie UMR1064, Université de Nantes, Nantes, France.
David BoutoilleService des Maladies Infectieuses et Tropicales, CHU Nantes, Nantes, France.
Katia GagneEtablissement Français du Sang, Nantes, France.
Audrey RodallecService de Virologie,CHU Nantes, Nantes, France.
Maeva LefebvreService des Maladies Infectieuses et Tropicales, CHU Nantes, Nantes, France.
François RaffiService des Maladies Infectieuses et Tropicales, CHU Nantes, Nantes, France.
David SenitzerDivision of Hematology and Bone Marrow Transplantation, City of Hope, National Medical Center, Duarte, California, USA.
Berthe-Marie Imbert-MarcilleCentre de Recherche en Transplantation et Immunologie UMR1064, Université de Nantes, Nantes, France.
Christelle RetièreEtablissement Français du Sang, Nantes, France christelle.retiere@efs.sante.fr.
Nantes Université · FRUniversité d'Angers · FRCity Of Hope National Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary human cytomegalovirus (HCMV) infection usually goes unnoticed, causing mild or no symptoms in immunocompetent individuals. However, some rare severe clinical cases have been reported without investigation of host immune responses or viral virulence. In the present study, we investigate for the first time phenotypic and functional features, together with gene expression profiles in immunocompetent adults experiencing a severe primary HCMV infection. Twenty primary HCMV-infected patients (PHIP) were enrolled, as well as 26 HCMV-seronegative and 39 HCMV-seropositive healthy controls. PHIP had extensive lymphocytosis marked by massive expansion of natural killer (NK) and T cell compartments. Interestingly, PHIP mounted efficient innate and adaptive immune responses with a deep HCMV imprint, revealed mainly by the expansion of NKG2C

Indexed as

Adaptive ImmunityAdultAgedCase-Control StudiesCell DifferentiationCell ProliferationCytomegalovirusCytomegalovirus InfectionsDisease SusceptibilityFemaleHumansImmunity, InnateKiller Cells, NaturalLymphocyte CountLymphocytosisMaleadaptive immunityHCMVinnate immunityNK cellsT lymphocytes

Identifiers

PMID28031361
PMCPMC5309965
OpenAlexW2567489795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.